Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border
Artemether-lumefantrine is the most widely used antimalarial artemisinin-based combination treatment. Recent studies have suggested that day 7 plasma concentrations of the potent metabolite desbutyl-lumefantrine correlate better with treatment outcomes than those of lumefantrine. Low cure rates have...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Society for Microbiology
2015
|
| _version_ | 1826276304007200768 |
|---|---|
| author | Kloprogge, F McGready, R Hanpithakpong, W Blessborn, D Day, N White, N Nosten, F Tarning, J |
| author_facet | Kloprogge, F McGready, R Hanpithakpong, W Blessborn, D Day, N White, N Nosten, F Tarning, J |
| author_sort | Kloprogge, F |
| collection | OXFORD |
| description | Artemether-lumefantrine is the most widely used antimalarial artemisinin-based combination treatment. Recent studies have suggested that day 7 plasma concentrations of the potent metabolite desbutyl-lumefantrine correlate better with treatment outcomes than those of lumefantrine. Low cure rates have been reported in pregnant women with uncomplicated falciparum malaria treated with artemether-lumefantrine in northwest Thailand. A simultaneous pharmacokinetic drug-metabolite model was developed based on dense venous and sparse capillary lumefantrine and desbutyl-lumefantrine plasma samples from 116 pregnant patients on the Thailand-Myanmar border. The best model was used to evaluate therapeutic outcomes with a time-to-event approach. Lumefantrine and desbutyl-lumefantrine concentrations, implemented in an Emax model, both predicted treatment outcomes, but lumefantrine provided better predictive power. A combined model including both lumefantrine and desbutyl-lumefantrine did not improve the model further. Simulations suggested that cure rates in pregnant women with falciparum malaria could be increased by prolonging the treatment course. (These trials were registered at controlled-trials.com [ISRCTN 86353884].). |
| first_indexed | 2024-03-06T23:11:56Z |
| format | Journal article |
| id | oxford-uuid:65c73cda-5240-427b-b373-e081766de313 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:11:56Z |
| publishDate | 2015 |
| publisher | American Society for Microbiology |
| record_format | dspace |
| spelling | oxford-uuid:65c73cda-5240-427b-b373-e081766de3132022-03-26T18:27:41ZLumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar borderJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:65c73cda-5240-427b-b373-e081766de313EnglishSymplectic Elements at OxfordAmerican Society for Microbiology2015Kloprogge, FMcGready, RHanpithakpong, WBlessborn, DDay, NWhite, NNosten, FTarning, JArtemether-lumefantrine is the most widely used antimalarial artemisinin-based combination treatment. Recent studies have suggested that day 7 plasma concentrations of the potent metabolite desbutyl-lumefantrine correlate better with treatment outcomes than those of lumefantrine. Low cure rates have been reported in pregnant women with uncomplicated falciparum malaria treated with artemether-lumefantrine in northwest Thailand. A simultaneous pharmacokinetic drug-metabolite model was developed based on dense venous and sparse capillary lumefantrine and desbutyl-lumefantrine plasma samples from 116 pregnant patients on the Thailand-Myanmar border. The best model was used to evaluate therapeutic outcomes with a time-to-event approach. Lumefantrine and desbutyl-lumefantrine concentrations, implemented in an Emax model, both predicted treatment outcomes, but lumefantrine provided better predictive power. A combined model including both lumefantrine and desbutyl-lumefantrine did not improve the model further. Simulations suggested that cure rates in pregnant women with falciparum malaria could be increased by prolonging the treatment course. (These trials were registered at controlled-trials.com [ISRCTN 86353884].). |
| spellingShingle | Kloprogge, F McGready, R Hanpithakpong, W Blessborn, D Day, N White, N Nosten, F Tarning, J Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border |
| title | Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border |
| title_full | Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border |
| title_fullStr | Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border |
| title_full_unstemmed | Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border |
| title_short | Lumefantrine and desbutyl-lumefantrine population pharmacokinetic-pharmacodynamic relationships in pregnant women with uncomplicated Plasmodium falciparum malaria on the Thailand-Myanmar border |
| title_sort | lumefantrine and desbutyl lumefantrine population pharmacokinetic pharmacodynamic relationships in pregnant women with uncomplicated plasmodium falciparum malaria on the thailand myanmar border |
| work_keys_str_mv | AT kloproggef lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT mcgreadyr lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT hanpithakpongw lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT blessbornd lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT dayn lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT whiten lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT nostenf lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder AT tarningj lumefantrineanddesbutyllumefantrinepopulationpharmacokineticpharmacodynamicrelationshipsinpregnantwomenwithuncomplicatedplasmodiumfalciparummalariaonthethailandmyanmarborder |